Sigma Healthcare (ASX:SIG) Other Financing: A$-86 Mil (TTM As of Dec. 2025)


ASX:SIG Sigma Healthcare Ltd ASX:SIG
59 GF Score
Price A$2.74
GF Value A$0.37
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Other Financing?

Sigma Healthcare ASX:SIG -0.36% 59 Other Financing is A$-86 Mil as of Dec. 2025. GuruFocus rates ASX:SIG with a GF Score™ of 59/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Sigma Healthcare's Other Financing for the six months ended in Dec. 2025 was A$-81 Mil.

Sigma Healthcare's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was A$-86 Mil.

Sigma Healthcare Other Financing Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare Other Financing Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.56 -16.38 -16.88 -9.50 -10.28

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.35 -81.15 -5.04 -5.24 -80.98
ASX:SIG
59GF Score
Sigma Healthcare Ltd ASX:SIG
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sigma Healthcare Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of A$-86 Mil mean?
Sigma Healthcare (ASX:SIG) has a Other Financing of A$-86 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sigma Healthcare and its competitors.
Is Sigma Healthcare's Other Financing too high?
Sigma Healthcare's current Other Financing is A$-86 Mil. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Other Financing compare to MCK and CAH?
Sigma Healthcare's Other Financing of A$-86 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Distribution company?
A good Other Financing depends on the Medical Distribution industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sigma Healthcare and its competitors. Sigma Healthcare's current Other Financing is A$-86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.74 — trading 640.5% above its estimated fair value. The current Other Financing is A$-86 Mil. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Other Financing is A$-86 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.74 is trading 640.5% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

  • Other Financing: A$-86 Mil
  • GF Value™: A$0.37 vs. price of A$2.74 (640.5% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for ASX:SIG

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.74
Price
A$0.37
GF Value